AllianceBernstein’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$989K Buy
121,439
+8,179
+7% +$66.6K ﹤0.01% 2294
2025
Q1
$889K Buy
113,260
+40,750
+56% +$320K ﹤0.01% 2302
2024
Q4
$1.08M Sell
72,510
-1,228,444
-94% -$18.3M ﹤0.01% 2298
2024
Q3
$19.9M Buy
1,300,954
+40,172
+3% +$614K 0.01% 916
2024
Q2
$19.2M Buy
1,260,782
+109,654
+10% +$1.67M 0.01% 902
2024
Q1
$21.7M Sell
1,151,128
-34,816
-3% -$657K 0.01% 846
2023
Q4
$22.7M Buy
1,185,944
+251,361
+27% +$4.8M 0.01% 837
2023
Q3
$16.8M Sell
934,583
-105,848
-10% -$1.9M 0.01% 904
2023
Q2
$21.1M Buy
1,040,431
+22,502
+2% +$457K 0.01% 840
2023
Q1
$18.6M Buy
1,017,929
+132,798
+15% +$2.42M 0.01% 870
2022
Q4
$18.3M Sell
885,131
-151,466
-15% -$3.13M 0.01% 863
2022
Q3
$27.1M Sell
1,036,597
-91,901
-8% -$2.4M 0.01% 736
2022
Q2
$28.6M Buy
1,128,498
+58,555
+5% +$1.48M 0.01% 744
2022
Q1
$33.8M Buy
1,069,943
+1,025,643
+2,315% +$32.4M 0.01% 724
2021
Q4
$1.79M Sell
44,300
-7,200
-14% -$291K ﹤0.01% 2194
2021
Q3
$1.8M Hold
51,500
﹤0.01% 2219
2021
Q2
$1.41M Buy
51,500
+6,500
+14% +$178K ﹤0.01% 2365
2021
Q1
$1.26M Buy
45,000
+1,100
+3% +$30.9K ﹤0.01% 2300
2020
Q4
$1.14M Hold
43,900
﹤0.01% 2231
2020
Q3
$752K Sell
43,900
-6,600
-13% -$113K ﹤0.01% 2305
2020
Q2
$1.25M Buy
50,500
+11,800
+30% +$292K ﹤0.01% 2086
2020
Q1
$537K Buy
38,700
+8,100
+26% +$112K ﹤0.01% 2308
2019
Q4
$309K Buy
30,600
+2,900
+10% +$29.3K ﹤0.01% 2757
2019
Q3
$252K Sell
27,700
-600
-2% -$5.46K ﹤0.01% 2849
2019
Q2
$225K Buy
28,300
+6,600
+30% +$52.5K ﹤0.01% 2922
2019
Q1
$271K Buy
21,700
+10,900
+101% +$136K ﹤0.01% 2796
2018
Q4
$116K Buy
+10,800
New +$116K ﹤0.01% 2975